Literature DB >> 9693092

Stabilization of antibody fragments in adverse environments.

H Dooley1, S D Grant, W J Harris, A J Porter.   

Abstract

Antibody fragments have the potential to be used as sensitive and specific binding agents in a broad range of industrial applications. Genetic manipulation has been used to design a series of antibody fragment configurations with a flexible linker and/or a disulphide bond between the heavy chain and light chain of an antibody fragment against the herbicide atrazine. The thermostability and stability to a range of denaturants, polar and non-polar solvents, surfactants and proteases have been compared. It has been found that a novel antibody fragment construct (STAB: stabilized antibody) containing both a flexible linker and a disulphide bond can be effectively produced and shows greatly improved stability in these diverse environments. These STABs should be useful in environmental diagnostics and remediation, and may provide a generic approach for stabilizing antibody fragments in formulations containing detergents and penetrants for topical application in the pharmaceutical and cosmetic industries.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9693092

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  6 in total

1.  Rapid isolation of a single-chain antibody against the cyanobacterial toxin microcystin-LR by phage display and its use in the immunoaffinity concentration of microcystins from water.

Authors:  Jacqui McElhiney; Mathew Drever; Linda A Lawton; Andy J Porter
Journal:  Appl Environ Microbiol       Date:  2002-11       Impact factor: 4.792

2.  First molecular and biochemical analysis of in vivo affinity maturation in an ectothermic vertebrate.

Authors:  Helen Dooley; Robyn L Stanfield; Rebecca A Brady; Martin F Flajnik
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

3.  A general approach to antibody thermostabilization.

Authors:  Audrey D McConnell; Xue Zhang; John L Macomber; Betty Chau; Joseph C Sheffer; Sorena Rahmanian; Eric Hare; Vladimir Spasojevic; Robert A Horlick; David J King; Peter M Bowers
Journal:  MAbs       Date:  2014       Impact factor: 5.857

Review 4.  Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies.

Authors:  Rahmad Akbar; Habib Bashour; Puneet Rawat; Philippe A Robert; Eva Smorodina; Tudor-Stefan Cotet; Karine Flem-Karlsen; Robert Frank; Brij Bhushan Mehta; Mai Ha Vu; Talip Zengin; Jose Gutierrez-Marcos; Fridtjof Lund-Johansen; Jan Terje Andersen; Victor Greiff
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

5.  Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability.

Authors:  Michael M Schmidt; Greg M Thurber; K Dane Wittrup
Journal:  Cancer Immunol Immunother       Date:  2008-04-12       Impact factor: 6.968

6.  Production of Single-Chain Fv Antibodies Specific for GA-Pyridine, an Advanced Glycation End-Product (AGE), with Reduced Inter-Domain Motion.

Authors:  Natsuki Fukuda; Kentaro Noi; Lidong Weng; Yoshihiro Kobashigawa; Hiromi Miyazaki; Yukari Wakeyama; Michiyo Takaki; Yusuke Nakahara; Yuka Tatsuno; Makiyo Uchida-Kamekura; Yoshiaki Suwa; Takashi Sato; Naoki Ichikawa-Tomikawa; Motoyoshi Nomizu; Yukio Fujiwara; Fumina Ohsaka; Takashi Saitoh; Katsumi Maenaka; Hiroyuki Kumeta; Shoko Shinya; Chojiro Kojima; Teru Ogura; Hiroshi Morioka
Journal:  Molecules       Date:  2017-10-10       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.